Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › ventricular septal defect

Ventricular septal defect

Part of Heart Defects, Congenital

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for ventricular septal defect

2 trials tracked for ventricular septal defect: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 5 citations.

2Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 2 1
  1. Phase 4 Regional Anesthesia Following Pediatric Cardiac Surgery Completed · 5 cited
  2. Phase 2 Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Synchronous PCG-ECG monitoring may supplement echocardiography for pediatric VSD subtype diagnosis
Pediatrics Cohort
Synchronous PCG-ECG monitoring may supplement echocardiography for pediatric VSD subtype diagnosis A Stethoscope Upgrade May Spot Holes in Kids' Hearts Faster
A prospective cohort study of 59 children with suspected ventricular septal defect (VSD) found that synchronous phonocardiogram-electrocardi…
A wearable device that records a child's heartbeat and heart sounds together may flag subtle differences between two kinds of heart holes.
Frontiers Apr 13, 2026

Research across Heart Defects, Congenital

Related studies from across the Heart Defects, Congenital family.

Percutaneous closure using the poly-L-lactic acid (PLLA) device in pediatric patients with atrial septal defect
Cardiology Cohort
Percutaneous closure using the poly-L-lactic acid (PLLA) device in pediatric patients with atrial septal defect New Device Closes Heart Holes in Kids
This prospective, single-center, first-in-human trial evaluated percutaneous closure using the poly-L-lactic acid (PLLA) device in 36 pediat…
A new milk-protein heart device closed holes in kids for five years, letting their bodies heal naturally without permanent metal implants.
Frontiers Apr 20, 2026